Chester County News and Community Website
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced its financial results for the third quarter of 2024, alongside significant progress in its lead program for firmonertinib, a …
ArriVent BioPharma Reports Advancements and Q3 2024 Financial Results Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has released its financial results for the third quarter ending September 30, 2024, alongside key updates on its clinical trials. The company …
Mineralys Therapeutics Reports Q3 2024 Results and Clinical Progress Read More
RADNOR, PA — Avantor, Inc. (NYSE: AVTR) has announced the appointment of Dame Louise Makin, DBE, Ph.D., to its Board of Directors. Her initial term is set to expire at Avantor’s …
Avantor Welcomes Dame Louise Makin to Board of Directors Read More
WAWA, PA — Wawa, Inc. is continuing its tradition of honoring veterans and their families by offering free hot coffee on Veterans Day, November 11, 2024. This gesture of gratitude will …
Wawa Honors Veterans with Free Coffee and Support Efforts Read More
CHESTER, PA — Price Rite Marketplace, in collaboration with Feed the Children, the Boys & Girls Club of Chester, and Butterball, hosted a significant distribution event on November 7, providing …
Price Rite Marketplace Joins Forces to Aid Chester Families Read More
RADNOR, PA — Lincoln Financial (NYSE: LNC) has announced that the board of directors of Lincoln National Corporation has declared a quarterly dividend of $562.50 per share on the corporation’s …
Lincoln Financial Announces Attractive Quarterly Dividend for Preferred Stockholders! Read More RADNOR, PA — Lincoln Financial (NYSE: LNC) has released its financial results for the third quarter ended September 30, 2024, revealing a net income loss but strong operational performance across …
Lincoln Financial Reports Strong Third Quarter Despite Net Income Loss Read More RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the swift completion of participant enrollment in its Launch-HTN trial, a critical component of its pivotal program investigating lorundrostat for the …
Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Pivotal Hypertension Trial Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has announced that its Phase 3 TrustTSC trial, which evaluated the use of oral ganaxolone for treating seizures in individuals with tuberous …
Marinus Pharmaceuticals Faces Setback with Phase 3 TrustTSC Trial Read More
BROOMALL, PA — Xactus has announced the appointment of Sasha Stair as its Chief Marketing Officer, marking a significant step in the company’s growth strategy. With over 20 years of …
Xactus Names Sasha Stair as Chief Marketing Officer Read More